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ABSTRACT 
The purpose of this study was to determine the phenotyping of Peripheral Blood 
Lymphocytes (PBL) in Head and Neck Cancers (HNCA) patients and to relate this with the 
level of Cell-Mediated Immunity (CMI) measured by in vitro lymphoproliferative assay, in 
order to evaluate immune suppression in HNCA patients and its possible mechanisms. 
Accordingly, one hundred twenty two HNCA patients and 100 control subjects were enrolled 
in this study. HNCA patients were classified into 42 nasopharyngeal carcinoma, 66 
carcinoma of larynx and 14 Hypo Pharyngeal Carcinoma (HPC). For measuring CMI, 
Microculture Tetrazolium assay (MTT) was applied on the freshly isolated lymphocytes of 
HNCA patients and control group. Immunophenotyping of PBL was carried out for 
monitoring the blood level of CD3+, CD4+, CD8+, CD21+ cells in HNCA patients in 
comparison with controls. The results of both assays have been integrated, revealed the 
presence of remarked immune suppression in HNCA patients in comparison with the 
controls, especially for NasoPharyngeal Carcinoma (NPC) patients who were 
immunosuppressed more than other studied HNCA types. Surprisingly, NPC group showed 
the lowest CMI level along with the highest level of PBL subsets, particularly NPC patients 
expressed the highest level of CD8+ cells among HNCA. It was inferred that CD8+ cells 
were more likely immune suppressor rather than cytotoxic cells and this is the principal factor 
for inducing sustained immunosuppression in HNCA and in NPC in particular. Furthermore 
CD4/CD8 ratio proved to be a reliable index for assessing the immunological status of 
HNCA patients and more dependable index than other immunity-evaluating factors. 
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